The Sonopet deal is worth $67 million in upfront payments to the company as well as potential future milestone and royalty payments of up to an additional $36 million.
OtisMed will become part of Stryker’s Orthopaedics division but will still be based in Alameda, Calif.
Read Stryker’s release on OtisMed and the Sonopet Ultrasonic Aspirator.